Merck & Company (MRK)

NYSE:MRK

MRK

Merck & Company

RESEARCH TOOLSreports

Compare Merck & Company (MRK) vs. Competitors

14,760 Followers

Comparison Results

MRK

Merck & Company

$122.68

$304.55B

14.46

49.77%

12 Buy

7 Hold

0 Sell

Moderate Buy

Gilead Sciences

$141.54

$176.37B

17.94

35.00%

17 Buy

5 Hold

0 Sell

Strong Buy

Novartis

$154.42

$282.16B

19.02

49.31%

3 Buy

3 Hold

0 Sell

Moderate Buy

Pfizer

$27.47

$154.78B

18.21

21.03%

8 Buy

13 Hold

2 Sell

Moderate Buy

Sanofi

$47.14

$113.92B

-31.42

-8.06%

1 Buy

1 Hold

0 Sell

Moderate Buy

AstraZeneca

15276.00 p

£236.91B

28.13

58.02%

13 Buy

2 Hold

1 Sell

Strong Buy

xxxxxxxxxxxxx

MRK vs AZN

xxxxxxxxxxxxx

Performance Comparison

MRK

Merck & Company

122.68

47.85

63.94%

GILD

Gilead Sciences

142.09

43.32

43.86%

NVS

Novartis

155.06

53.65

52.90%

PFE

Pfizer

27.22

7.09

35.23%

SNY

Sanofi

47.08

-1.05

-2.18%

GB:AZN

AstraZeneca

15,276.00

5,429.61

55.14%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >